LITS
Lite Strategy, Inc.
NASDAQ: LITS · HEALTHCARE · BIOTECHNOLOGY
$1.15
+0.00% today
Updated 2026-04-30
Market cap
$42.54M
P/E ratio
—
P/S ratio
0.31x
EPS (TTM)
$-1.82
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Lite Strategy, Inc. (LITS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-76.40%
ROA
-19.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $34.80M | $-41.31M | 95.95% | -173.65% | -118.73% |
| 2022 | $40.70M | $-54.45M | 100.00% | -185.48% | -133.80% |
| 2023 | $48.82M | $-31.84M | 100.00% | -75.31% | -65.22% |
| 2024 | $65.30M | $17.78M | 100.00% | 22.27% | 27.23% |
| 2025 | $0.00 | $-15.95M | — | — | — |